The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index; none of the 123 sources its claims cite is checked for support yet.
The telomere syndromes
Open accessAbstract
There has been mounting evidence of a causal role for telomere dysfunction in a number of degenerative disorders. Their manifestations encompass common disease states such as idiopathic pulmonary fibrosis and bone marrow failure. Although these disorders seem to be clinically diverse, collectively they comprise a single syndrome spectrum defined by the short telomere defect. Here we review the manifestations and unique genetics of telomere syndromes. We also discuss their underlying molecular mechanisms and significance for understanding common age-related disease processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 123 cited sources checked · 0 supported · 0 flagged
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There has been mounting evidence of a causal role for telomere dysfunction in a number of degenerative disorders.”
- Also stated in: § Abstract · boosted
“This Review highlights how recent discoveries in human genetics have synergized with the field of telomere biology to unequivocally establish a causal role for telomere dysfunction in several specific, common and recognizable disease contexts.”
§ The telomere syndromes > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Abstract · boosted
In the paper
“Among these, the lung disease idiopathic pulmonary fibrosis (IPF) — best known until recently by its ‘idiopathic’ adjective — is the most common manifestation of telomere-mediated disease12.”
§ The telomere syndromes > Abstract
What the sources say
- Not checked yetcites [12] Armanios, M. Telomerase and idiopathic pulmonary fibrosis. Mutat. Res. 730, 52–58 (2012). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because, as we discuss, telomere length is heritable, the unique inheritance patterns that distinguish these syndromes from other Mendelian disorders are also discussed.”
- Also stated in: § Heritability of telomere length in humans · plain
“These observations collectively support that telomere length is a genetically determined trait and that short telomeres are probably sufficient to cause disease phenotypes within similar thresholds to those seen in monogenic disorders.”
§ The telomere syndromes > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Heritability of telomere length in humans · plain
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These observations collectively support that telomere length is a genetically determined trait and that short telomeres are probably sufficient to cause disease phenotypes within similar thresholds to those seen in monogenic disorders.”
§ The telomere syndromes > Telomere length is a heritable trait > Heritability of telomere length in humans
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Mutations in TERT and TR are the most commonly identifiable defects in monogenic telomere syndromes.”
§ The telomere syndromes > Genotype–phenotype correlations > Telomere length is a modifier of disease severity
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Although these disorders seem to be clinically diverse, collectively they comprise a single syndrome spectrum defined by the short telomere defect.”
- Also stated in: § Abstract · hedged
“Because of their overlapping clinical features, it has been proposed to consider them as a single syndrome spectrum13, and here we refer to them as ‘the telomere syndromes.’”
§ The telomere syndromes > Abstract
What the sources say
- Not checked yetcites [13] Armanios, M. Syndromes of telomere shortening. Annu. Rev. Genom. Hum. Genet. 10, 45–61 (2009). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The short telomere defect in affected individuals is present in germ cells and thus simultaneously affects multiple organs even when one disease presentation predominates.
- Also stated in: § Abstract · hedged
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“As described below, mutations in the genes that encode the essential telomerase components — namely, TERT, TR and DKC1 — are a common cause of human telomere syndromes.”
§ The telomere syndromes > Telomeres and telomerase > Telomerase structure
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that at least three primary mechanisms explain the diverse telomere-mediated disease phenotypes.”
§ The telomere syndromes > Mechanisms of telomere-mediated disease
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Clinically, this is most apparent in the high penetrance of pulmonary disease in telomerase mutation carriers, even though the lung has a slow mitotic rate56,99.”
§ The telomere syndromes > Mechanisms of telomere-mediated disease
What the sources say
- Not checked yetcites [56] Armanios, M. Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317–1326 (2007). References 54–56 showed that lymphocyte telomere length using flow cytometry and fluorescence in situ hybridization could be a useful diagnostic marker in identifying individuals with telomere-related disease. source
- Not checked yetcites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Altogether, mutations in four genes — DKC1, TINF2, TERT and TR — account for most dyskeratosis congenita cases with an identifiable genetic defect.”
§ The telomere syndromes > The monogenic telomere disorders > Childhood-onset telomere disorders
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- It may state two separate claims as one. 23
None of the sources cited for this claim have been checked yet.
In the paper
“They manifest in an autosomal-dominant inheritance pattern because complete or partial loss-of-function of one allele is sufficient to perturb telomere maintenance38,39,41.”
§ The telomere syndromes > Genotype–phenotype correlations > Telomere length is a modifier of disease severity
What the sources say
- Not checked yetcites [38] Vulliamy, T. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432–435 (2001). source
- Not checked yetcites [39] Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005). References 38 and 39 identified mutations in the essential telomerase genes, TERT and TR , in dyskeratosis congenita. source
- Not checked yetcites [41] Yamaguchi, H. et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352, 1413–1424 (2005). This study identified TERT mutations in patients with aplastic anaemia. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In addition to studies in families, a number of population-based twin and non-twin studies have shown that parental telomere length (especially the paternal) influences offspring telomere length with heritability estimates ranging from 0.36–0.84 (reviewed in Ref. 90).”
§ The telomere syndromes > Telomere length is a heritable trait > Heritability of telomere length in humans
What the sources say
- Not checked yetcites [90] Aviv, A. Genetics of leukocyte telomere length and its role in atherosclerosis. Mutat. Res. 730, 68–74 (2012). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“When quantified, telomere length is short in wild-type offspring of parent M. castaneus mice that have short telomeres, indicating that telomere length is inherited36,82”
- Also stated in: § Evidence from mouse studies · plain
“Therefore, telomere length is inherited as a unique genotype, and its inheritance can be uncoupled from the telomerase and telomere gene loci.”
§ The telomere syndromes > Telomere length is a heritable trait > Evidence from mouse studies
What the sources say
- Not checked yetcites [36] Hao, L. Y. et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123, 1121–1131 (2005). In reference 36, using CAST/EiJ mice that have telomere length similar to humans, this paper established that telomerase haploinsufficiency is sufficient to cause dyskeratosis-congenita-like phenotypes. It also showed that telomere length is inherited and can cause degenerative phenotypes even when telomerase is wild-type. source
- Not checked yetcites [82] Armanios, M. et al. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 85, 823–832 (2009). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Evidence from mouse studies · plain
In the paper
“In earlier generations, pulmonary fibrosis is usually the primary manifestation, whereas in later generations, bone marrow failure in younger individuals is seen as a first complication71.”
§ The telomere syndromes > Genotype–phenotype correlations > Telomere length is a modifier of disease type
What the sources say
- Not checked yetcites [71] Parry, E. M., Alder, J. K., Qi, X., Chen, J. J. & Armanios, M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 117, 5607–5611 (2011). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Telomere disorders most commonly manifest as adult-onset disease and as a consequence of germline TERT or TR loss-of-function mutations13.”
§ The telomere syndromes > The monogenic telomere disorders > Adult-onset manifestations of telomere-mediated disease
What the sources say
- Not checked yetcites [13] Armanios, M. Syndromes of telomere shortening. Annu. Rev. Genom. Hum. Genet. 10, 45–61 (2009). source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The consequent signalling cascades activate checkpoints that induce either cellular senescence or apoptosis, and in at least some contexts both processes occur simultaneously82,85,91,95.”
§ The telomere syndromes > Mechanisms of telomere-mediated disease
What the sources say
- Not checked yetcites [82] Armanios, M. et al. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 85, 823–832 (2009). source
- Not checked yetcites [85] Lee, H. W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998). References 84 and 85 are two landmark papers that established that telomerase itself is not essential and that short telomeres cause apoptosis and cell loss in high-turnover tissues. source
- Not checked yetcites [91] d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198 (2003). source
- Not checked yetcites [95] Hemann, M. T. et al. Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol. Biol. Cell 12, 2023–2030 (2001). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, the cancer-related mortality is limited to approximately 10% of dyskeratosis congenita cases, with the remaining mortality attributable to the degenerative disease phenotypes described above.”
§ The telomere syndromes > The monogenic telomere disorders > Telomere syndromes predispose to cancer
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The frequency of these mutations is highest in individuals with the progressive disorder IPF, which accounts for 8–15% of familial and 1–3% of sporadic cases54,56,68,69.”
§ The telomere syndromes > The monogenic telomere disorders > Adult-onset manifestations of telomere-mediated disease
What the sources say
- Not checked yetcites [54] Alder, J. K. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl Acad. Sci. USA 105, 13051–13056 (2008). source
- Not checked yetcites [56] Armanios, M. Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317–1326 (2007). References 54–56 showed that lymphocyte telomere length using flow cytometry and fluorescence in situ hybridization could be a useful diagnostic marker in identifying individuals with telomere-related disease. source
- Not checked yetcites [68] Tsakiri, K. D. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl Acad. Sci. USA 104, 7552–7557 (2007). References 56 and 68 identified mutations in the essential telomerase genes in familial pulmonary fibrosis. source
- Not checked yetcites [69] Cronkhite, J.T. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178, 729–737 (2008). source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hence, the degree of telomere shortness is a determinant of both disease severity and type.”
§ The telomere syndromes > Genotype–phenotype correlations > Telomere length is a modifier of disease type
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The downstream effector pathways of telomere-induced senescence are largely p53-dependent96, but there may be involvement of the retinoblastoma protein (RB) pathway in some settings97.”
§ The telomere syndromes > Mechanisms of telomere-mediated disease
What the sources say
- Not checked yetcites [96] Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999). source
- Not checked yetcites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Eight mutant genes have been identified in dyskeratosis congenita9,38,39,60–64, and all of them encode telomerase or telomere protein components (summarized in Table 1).”
§ The telomere syndromes > The monogenic telomere disorders > Childhood-onset telomere disorders
What the sources say
- Not checked yetcites [9] Heiss, N. S. et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nature Genet. 19, 32–38 (1998). This study identified mutations in the X-linked DKC1 gene as a first cause of dyskeratosis congenita. source
- Not checked yetcites [38] Vulliamy, T. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432–435 (2001). source
- Not checked yetcites [39] Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005). References 38 and 39 identified mutations in the essential telomerase genes, TERT and TR , in dyskeratosis congenita. source
- Not checked yetcites [60] Vulliamy, T. et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc. Natl Acad. Sci. USA 105, 8073–8078 (2008). source
- Not checked yetcites [61] Walne, A. J. et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum. Mol. Genet. 16, 1619–1629 (2007). source
- Not checked yetcites [62] Savage, S. A. et al. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am. J. Hum. Genet. 82, 501–509 (2008). This paper was the first to show that mutations in a shelterin component are a cause of dyskeratosis congenita. source
- Not checked yetcites [63] Zhong, F. et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev. 25, 11–16. source
- Not checked yetcites [64] Keller, R. B. et al. CTC1 mutations in a patient with dyskeratosis congenita. Pediatr. Blood Cancer 59, 311–314 (2012). source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“When examining telomere measurements within a mixed cell population, it is important to note that this is a surrogate marker of the mean in a heterogeneous cell population and that telomere length is mosaic, reflecting the telomere length regulation and replicative history of each cell type51,52.”
§ The telomere syndromes > Telomere length measurement
What the sources say
- Not checked yetcites [51] Lin, J. et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J. Immunol. Methods 352, 71–80 (2010). source
- Not checked yetcites [52] Rufer, N. et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med. 190, 157–167 (1999). source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The limitation on the telomerase synthesis reaction on human telomeres favours telomere shortening as a general default state and means that telomere shortening generally accompanies cell proliferation.”
§ The telomere syndromes > Telomeres and telomerase > Elongation of telomeres by telomerase is tightly regulated
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This idea is consistent with the fact that telomerase activity is upregulated in most human cancers, which probably contributes to sustaining their immortality7.”
§ The telomere syndromes > Telomeres and telomerase > Elongation of telomeres by telomerase is tightly regulated
What the sources say
- Not checked yetcites [7] Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994). In this study, telomerase activity was found to be enriched in cancer and germ cells, suggesting that telomerase has a role in extending replicative potential. source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The telomere syndromes are highly relevant for understanding age-related disease because the short telomere defect that they share is acquired with age.”
§ The telomere syndromes > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
- Rests on an assumption: The short telomere defect shared by telomere syndromes is acquired with age.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The shared underlying telomere defect in aplastic anaemia and IPF brings together clinical entities that were previously considered to be disparate and defines a recognizable syndrome complex that predominantly manifests in adults, in contrast to dyskeratosis congenita.”
§ The telomere syndromes > The monogenic telomere disorders > The telomere syndrome concept
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Telomere elongation is cell-cycle-regulated; telomerase elongates telomeric DNA by adding telomere repeats during S phase and into M phase32,33.”
§ The telomere syndromes > Telomeres and telomerase > Elongation of telomeres by telomerase is tightly regulated
What the sources say
- Not checked yetcites [32] Diede, S. J. & Gottschling, D. E. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases α and δ. Cell 99, 723–733 (1999). source
- Not checked yetcites [33] Marcand, S., Brevet, V., Mann, C. & Gilson, E. Cell cycle restriction of telomere elongation. Curr. Biol. 10, 487–490 (2000). source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Indeed, the co-occurrence of IPF and bone marrow failure, along with liver cirrhosis, is specific to and highly predictive of a germline telomere maintenance defect13,39,71.”
§ The telomere syndromes > The monogenic telomere disorders > The telomere syndrome concept
What the sources say
- Not checked yetcites [13] Armanios, M. Syndromes of telomere shortening. Annu. Rev. Genom. Hum. Genet. 10, 45–61 (2009). source
- Not checked yetcites [39] Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005). References 38 and 39 identified mutations in the essential telomerase genes, TERT and TR , in dyskeratosis congenita. source
- Not checked yetcites [71] Parry, E. M., Alder, J. K., Qi, X., Chen, J. J. & Armanios, M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 117, 5607–5611 (2011). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Therefore, it seems that telomere-induced senescence represents more than a loss of replicative potential and can limit cellular function even when cells appear morphologically intact97.”
§ The telomere syndromes > Mechanisms of telomere-mediated disease > Exocytosis defects in pancreatic β-cells
What the sources say
- Not checked yetcites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Telomere syndromes represent an archetype of premature-ageing syndromes because the short telomere defect they share is progressively acquired with age in humans.”
§ The telomere syndromes > Summary and implications
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Beyond its canonical phenotypes in high-turnover tissues, telomere dysfunction is sufficient to cause — and indeed commonly causes — degenerative phenotypes in slow-turnover tissues.”
§ The telomere syndromes > Summary and implications
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Although they appear morphologically normal, mouse β-cells with dysfunctional telomeres show the hallmarks of senescence. They have an activated DNA damage response, impaired proliferation, p16INK4A upregulation and altered gene expression97.”
§ The telomere syndromes > Mechanisms of telomere-mediated disease > Exocytosis defects in pancreatic β-cells
What the sources say
- Not checked yetcites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The fact that the gene expression changes that occur during telomere-induced senescence cause functional changes in the absence of structural tissue disruption highlights a novel mechanism by which senescence and its associated gene expression changes cause disease.”
§ The telomere syndromes > Mechanisms of telomere-mediated disease > Exocytosis defects in pancreatic β-cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
The short telomere defect shared by telomere syndromes is acquired with age.
“The telomere syndromes are highly relevant for understanding age-related disease because the short telomere defect that they share is acquired with age.”
The paper relies on this without support.
The short telomere defect in affected individuals is present in germ cells and thus simultaneously affects multiple organs even when one disease presentation predominates.
“Their grouping together as a syndrome spectrum is crucial for clinical decisions because the short telomere defect in affected individuals is present in germ cells and thus simultaneously affects multiple organs even when one disease presentation predominates.”
The paper relies on this without support.
Allogeneic stem cell transplantation can reverse aplastic anaemia in humans.
“In humans, the aplastic anaemia phenotype can be reversed with allogeneic stem cell transplant, indicating that this telomere-related stem cell failure state is primarily cell-autonomous.”
The paper relies on this without support.
Smoking hastens disease onset in people who carry telomerase mutations.
“Instead, a second insult is required, and when mice with short telomeres are experimentally exposed to cigarette smoke, which is known to accelerate disease onset in human telomerase mutation carriers, they develop lung disease99.”
The paper relies on this without support.
β-cells in adult mouse pancreatic islets turn over slowly, roughly 4% each week.
“This mechanism has been elucidated in adult mouse β-cells of the pancreatic islets, which have a fairly slow turnover (4% per week).”
The paper relies on this without support.
Blood formation depends on a small set of stem cells that can self-renew and differentiate.
“Haematopoiesis relies on the self-renewal and differentiation capacity of a well-characterized oligoclonal stem cell compartment.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Telomerase deficiency in humans is associated with premature development of diseases, such as pulmonary fibrosis, dyskeratosis congenita and aplastic anemia, which involve the loss of the regenerative capacity of different tissues (Armanios and Blackburn, 2012).”
From The Hallmarks of Aging (2013) · cites this paper as Armanios and Blackburn, 2012
Experimental — accuracy not yet measuredIn the citing paper
“Progerias or premature aging, or the short telomere syndromes include genetic diseases associated with short telomeres and premature senescence [59].”
From Markers of cellular senescence. Telomere shortening as a marker of cellular senescence (2016) · cites this paper as [59]
In the citing paper
“Rare Mendelian human mutations compromising telomere maintenance or protection genes cause early death and diseases involving a wide variety of tissues and organ systems (Armanios and Blackburn, 2012).”
From Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) · cites this paper as Armanios and Blackburn, 2012
In the citing paper
“The ribonucleoprotein enzyme telomerase provides the major mechanism for telomere preservation and length replenishment (Armanios and Blackburn, 2012; Chakhparonian and Wellinger, 2003) (Fig 1).”
From Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) · cites this paper as Armanios and Blackburn, 2012
In the citing paper
“Inherited telomerase deficiencies resulting in a two-fold drop in gene dosage are directly linked to malignancies and several other diseases in humans (Armanios and Blackburn, 2012).”
From Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) · cites this paper as Armanios and Blackburn, 2012
In the citing paper
“Short telomeres have been linked to numerous diseases of aging and in many but not all cases, to all-cause and disease-specific mortality (12–17).”
From Determinants of telomere attrition over 1 year in healthy older women: stress and health behaviors matter (2015) · cites this paper as [12]
In the citing paper
“stress appears to augment replicative TL shortening, perhaps by promoting nonenzymatic hydrolysis of telomere base pairs (11,18).”
From Social disadvantage, genetic sensitivity, and children's telomere length (2014) · cites this paper as [18]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M. A. C., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., & Wu, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6622 · Cited by 2,326
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–975 of 975
Opresko, P. L., & Barnes, R. P. (2022) · doi:10.64628/aai.sjn7asaca
Wen, D.-N., Hu, J.-H., Ji, T., Xiao, X.-Y., Huang, X.-C., Zhang, J.-F., Feng, W.-B., Shuo, Z., Xiong, Z.-Y., & Hou, C.-L. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120268
Telomeropathy: an often overlooked but unifying diagnosis
Coalter, M., Temperley, H. C., Fahy, R. J., Flynn, C., & Lavin, M. (2025) · QJM · doi:10.1093/qjmed/hcaf211
Exploring the spectrum of central nervous system tumours in carriers of germline POT1 variants
Nielsen, E. N., Jelsig, A. M., Foss-Skiftesvik, J., Lohse, Z., Timshel, S., Borgwardt, L. G., Hansen, T. V. O., & Wadt, K. (2025) · Journal of Medical Genetics · doi:10.1136/jmg-2025-110679
Donor leukocyte telomere length emerges as a prognostic factor for transplantation outcomes
Wu, H., Yu, J., Cao, Y., Wei, R., Shi, W., Yu, Y., Shi, Z., Shi, J., Luo, Y., Yu, J., et al. (2025) · The Innovation · doi:10.1016/j.xinn.2025.101147
Idiopathic Pulmonary Fibrosis and Rare Lung Disorders
Aphale, P., Shekhar, H., & Dokania, S. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4923-7.ch008
A Comprehensive Catalog of Telomere Content Variation Across Human PopulationsPreprint
Shah, P., & Sethuraman, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.03.686324
αG-Rutin Mitigates Telomere Attrition and Prevents Cellular Senescence
Terada, T., Sahayasheela, V. J., Noizumi, R., Nakanishi, A., Tandia, M., & Sugiyama, H. (2025) · ACS Nutrition Science · doi:10.1021/acsnutrsci.5c00012
REPAIR OF BIPYRIMIDINE PHOTOPRODUCTS AT TELOMERES OF ULTRAVIOLET LIGHT IRRADIATED MAMMALIAN CELLS
Parikh, D. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Wang, C., Songyang, Z., & Huang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15085867
Wang, C., Songyang, Z., & Huang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15085864
Adam, E., Ranjan, D., & Riethman, H. C. (2024) · Figshare · doi:10.6084/m9.figshare.26555267
Wang, T., Jia, Z., Li, S., Li, Y., Yu, T., Lu, T., & Shi, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20522597
Wang, C., Songyang, Z., & Huang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15085858
Artois, T. J., & Tessens, B. (2008) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.183376
Bergantini, L., Baldassarri, M., d’Alessandro, M., Brunelli, G., Fabbri, G., Zguro, K., Degl’Innocenti, A., Fallerini, C., Bargagli, E., & Renieri, A. (2024) · Figshare · doi:10.6084/m9.figshare.26597873
Wang, C., Songyang, Z., & Huang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15085861
Adam, E., Ranjan, D., & Riethman, H. C. (2024) · Figshare · doi:10.6084/m9.figshare.26555264
Not So Benign Telomere Biology Disorders: Not So Benign, Not So Rare, and Not Limited to Pediatrics
Mangaonkar, A. A., Shah, S., & Patnaik, M. M. (2026) · The Hematologist · doi:10.1182/hem.v23.1.202612
CNT@PEI-TRP-based sensing platform: Tracking nanoscale DNA length variations
Zhao, X., Li, Y., Xu, W., Ye, T., Wang, X., Xu, J., & Chen, L. (2026) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2026.139612
Manna, T., & Das, S. P. (2026) · Research Square · doi:10.21203/rs.3.rs-8814520/v1
Centromeres and telomeres as rheological probes of the human cell nucleus
Clavijo, A. S., Ionov, S., & Zidovska, A. (2026) · Biophysical Journal · doi:10.1016/j.bpj.2026.02.023
Marchi, L. F., & Biazotto, G. A. (2025) · Revista Master Ensino Pesquisa e Extensão · doi:10.47224/revistamaster.v10i20.672
Uyen, L. T. H., Duyen, V. T. C., & Truong, P. L. (2026) · RSC Advances · doi:10.1039/d5ra08471g
Modified hTERT treatment ameliorates pressure overload-induced heart failure
Zhao, Y., Bao, X., Xiong, W., Wan, X., Yu, Q., Wang, T., Chang, A. C. H., Liu, Y., Wang, Y., Shang, C., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106203
Yang, R., Zhang, J., Feng, X., Huang, R., Wang, W., Chen, W., Liu, Y., Chen, T., Bai, J., Lei, H., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117902
Gerontology: pathophysiological mechanisms of human development
Sushchevich, V. (2026) · Healthcare · doi:10.65249/1027-7218-2026-2-45-57
Telomere Length in Celiac Disease in a Population-Based Cohort: A HUNT Study
Fossmark, R., Hjorth‐Hansen, H., Lirussi, L., Lüders, T., Visnovska, T., Liu, Y., Salvesen, Ø. O., Nilsen, H. L., & Ness‐Jensen, E. (2026) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000001020
Type 2 Diabetes From the Perspective of Telomere Biology
Cao, H., Feng, H., Shen, Z., & Huang, Y. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70137
Aetiology of Aplastic Anemia and Inherited Bone Marrow Failure Syndromes
Gopi, P., Karthikeyan, A., & Kar, R. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-026-02397-5
Etude de l'instabilité génomique et du statut des télomères dans le cancer du sein.
Gay‐Bellile, M. (2017) · theses.fr (ABES) · doi:10.70675/320a4136z144cz4b1ezb9e2z5cc2471afa58
Biogenesis and Function of H3K9me3 at telomeres of mouse embryonic stem cells
Kan, S. (2015) · theses.fr (ABES) · doi:10.70675/cbaee4b0z64cez4b4eza882zbaf2c49e74a0
Implication de la voie p53 dans les syndromes d'insuffisance médullaire
Toufektchan, E. (2018) · theses.fr (ABES) · doi:10.70675/58dfec7cz94b0z449fz96a6z9051bf80c551
Kychygina, G. (2019) · theses.fr (ABES) · doi:10.70675/257216a4zfec4z40ccza35bz81fab5ab7e1e
Teissier, T. (2019) · theses.fr (ABES) · doi:10.70675/f49bc069z5ee6z4c49zb46fz0a1413dbba95
Développement d'une stratégie Cheval de Troie dans le traitement du carcinome hépatocellulaire
Nayagom, B. (2019) · theses.fr (ABES) · doi:10.70675/780d49f6zde47z4ff1z9bc4z7e014070104c
Age-specific relationships between immunity and life-history traits in a wild mammal
Cheynel, L. (2018) · theses.fr (ABES) · doi:10.70675/68380a80zb8a0z443fz9019z3fcc79a6f371
Personalised medicine approaches for investigation and application of new biomarkers
Gorenjak, V. (2019) · theses.fr (ABES) · doi:10.70675/f44144aaz4538z45abz9ce9za155e0c2e883
Spatio-temporal regulation of telomere recombination during replicative senescence
Aguilera, P. (2018) · theses.fr (ABES) · doi:10.70675/96005af7zd504z47b7z95cbzdb2c49aea036
Billard, P. (2021) · theses.fr (ABES) · doi:10.70675/7d145f6az2700z4c8bzad56z3286d493fb31
Maintenance des télomères dans la carcinogenèse hépatique : fonction et transfert vers la clinique
Ningarhari, M. (2022) · theses.fr (ABES) · doi:10.70675/f313264az1d77z4572z8a2dz6fc821d54a58
Implication de la voie p53 dans les syndromes d'insuffisance médullaire
Durand, R. (2020) · theses.fr (ABES) · doi:10.70675/6ccc120bz65f7z4c6czabf5z9bea26651b66
Effet de position télomérique : implications dans la régulation du génome et les maladies rares
Chevalier, R. (2022) · theses.fr (ABES) · doi:10.70675/89769afeza443z495cz9933z31ab8621510e
Telomere dynamics and life-history traits
Remot, F. (2022) · theses.fr (ABES) · doi:10.70675/4f13b16fzd2b9z4e95z8af2z29581b8addb4
Molecular and Cellular Responses to the Shortest Telomere in Saccharomyces cerevisiae
Berardi, P. (2024) · theses.fr (ABES) · doi:10.70675/7b7d608bza43cz4696z9e55z6043326f7d64
Rakotopare, J. (2024) · theses.fr (ABES) · doi:10.70675/cc79cc10zbaf8z4e88za003z8a8d37707576
Leo, B., Hartandy, I., Hutajulu, S. H., Hardianti, M. S., Widayati, K., Kurnianda, J., & Purwanto, I. (2026) · Journal of Medical Case Reports · doi:10.1186/s13256-026-06011-0
Cross species activity of TERT human telomerase component
Sánchez-Vazquez, R., Paula, M., Saha, A., & Blasco, M. A. (2026) · Aging · doi:10.18632/aging.206372
Holbrooks, J. S., Loveless, C. A., Vogler, K. A., Reed, S. D., Duvall, G. H., Romney, C. V., Ackerson, S. M., Kircher, M. B., & Stewart, J. A. (2026) · Journal of Cell Science · doi:10.1242/jcs.264269
Monaghan, P. G., Johnson, K. A., Bove, R. M., Fling, B. W., & Fritz, N. E. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2676826
The Bio-Social Pathology of Modern Urban Life: Loneliness, Social Isolation and Telomere Shortening
Aslan, G. I., Bozkaya, A., & YILDIRIMER, P. D. K. Ş. (2026) · International Journal of Social Science and Human Research · doi:10.47191/ijsshr/v9-i5-81
Lu, X.-Y., Wang, Y.-G., & Wang, H. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i21.116363
Pandey, S. N., Afzal, M., Rekha, A., Vijayan, M. P., Uniyal, P., Maji, C., Khan, A., Thangavelu, L., & Nagaraj, K. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112212
Telomerase hype in consumer health: When “longevity tech” outruns evidence
Khan, Z. U., Sarnaik, A. Y., & Butt, Z. A. (2026) · Health Policy and Technology · doi:10.1016/j.hlpt.2026.101276
Franke, M., Lasho, T. L., Finke, C. M., Simon, R. A., Fernandez, J. A., Ongie, L. J., McCullough, K. B., Carmona, E. M., Simonetto, D. A., Mangaonkar, A. A., et al. (2026) · American Journal of Hematology · doi:10.1002/ajh.70421
Inherited long telomeres induce a genome-wide transcriptional response in budding yeast
Sidarava, V., & Lydall, D. A. (2026) · Genetics · doi:10.1093/genetics/iyag174
Anemia in Bone Marrow Failure: Mechanism and Clinical Management
Zhumatayev, S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016332
Positioning TERT at the apex of aging
DePinho, R. A. (2026) · Nature Aging · doi:10.1038/s43587-026-01179-y
Advances and challenges in cell-based therapy for lung diseases
Wallman, D. J., Alhawach, V., Hawkins, F. J., & Lynch, T. J. (2026) · Cytotherapy · doi:10.1016/j.jcyt.2026.102971
Telomere variant sequences encode the genetic blueprint for allele-specific telomere length
Chai, X., Poon, L.-F., Liu, H., Singh, M. K., Minami, T., Sashida, G., Fukuda, M., Teh, B. T., Tan, P. B. O., Hwang, W. Y. K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77310-9
Feng, B., Yang, R., Wang, G., Hu, Q., & Zhao, C. (2026) · Annals of Human Genetics · doi:10.1111/ahg.70057
Recommendations for return of secondary genomic findings in observational cohort studies
Kullo, I. J., Horowitz, C. R., Bastarache, L. A., Berkman, B. E., Biesecker, L. G., Brothers, K. B., Carson, A. P., Diaz, K. M., Gibbs, R. A., Green, R. C., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02724-6
Cirrhosis caused by RTEL1-Associated Telomeropathy
de Callataÿ, M., Timmery, E., & Delire, B. (2026) · Acta gastro-enterologica belgica · doi:10.51821/89.3.14768
Metadata
- Authors
- Armanios, M., & Blackburn, E. H.
- Affiliations
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- Corresponding author
- Armanios, Mary
- Venue
- Nature Reviews Genetics
- Published
- 2012-09-11
- Volume
- 13
- Issue
- 10
- Pages
- 693-704
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- PMC
- PMC3548426
- OpenAlex
- W1981775109
- Cited by
- 982
- References
- 128
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 50 · 2023: 63 · 2022: 68 · 2021: 92 · 2020: 74 · 2019: 79 · 2018: 81 · 2017: 84 · 2016: 82 · 2015: 80 · 2014: 71 · 2013: 59 · 2012: 8
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-02-12)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R21HL104345)
- National Cancer Institute (R01CA160433)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomere dysfunction, telomere maintenance, short telomeres, cellular aging, idiopathic pulmonary fibrosis, bone marrow failure, degenerative diseases, mode of inheritance, age-related diseases, telomere biology
- MeSH terms
- Animals, Humans, Models, Biological, Syndrome, Telomere, Quantitative Trait, Heritable, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review